Use of Serum Protein Measurements as Biomarkers that Can Predict the Outcome of Diabetic Foot Ulceration-Reference-Cited by-同舟云学术

Use of Serum Protein Measurements as Biomarkers that Can Predict the Outcome of Diabetic Foot Ulceration

Published:2024-09-01 Issue:9 Volume:13 Page:426-434
ISSN:2162-1918
Container-title:Advances in Wound Care
language:en
Short-container-title:Advances in Wound Care

Author:

Theocharidis Georgios¹²^ORCID,Sumpio Brandon¹²,Wang Enya¹,Mezghani Ikram¹,Giurini John M.¹²,Kalavros Nikolaos³,Valsami Eleftheria-Angeliki¹²,Vlachos Ioannis²³,Heydarpour Mahyar²⁴,Veves Aristidis¹²^ORCID

Affiliation:

1. Joslin-Beth Israel Deaconess Foot Center and The Rongxiang Xu, MD, Center for Regenerative Therapeutics, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

2. Harvard Medical School, Boston, Massachusetts, USA.

3. Department of Pathology, Cancer Research Institute, HMS Initiative for RNA Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

4. Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, Mass General Brigham, Boston, Massachusetts, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/wound.2023.0126

Reference22 articles.

1. Diabetic Foot Ulcers and Their Recurrence

2. Resurgence of Diabetes-Related Nontraumatic Lower-Extremity Amputation in the Young and Middle-Aged Adult U.S. Population

3. Burden of Diabetic Foot Ulcers for Medicare and Private Insurers

4. Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind study

5. Graftskin, a Human Skin Equivalent, Is Effective in the Management of Noninfected Neuropathic Diabetic Foot Ulcers